Rotavac 5D 5 ml Oral liquid
PDF Leaflet Revision Date: 08 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation of infants from 6 weeks for prevention of rotavirus gastroenteritis.
Dosage (summary)
0.5 ml (5 drops) orally, 3 doses 4 weeks apart starting at 6 weeks of age.
Special Populations
- Immunocompromised infants
- Infants with HIV
Pregnancy & Breastfeeding
Not for use in adults or pregnant women; breastfeeding is permitted.
Key Drug Interactions
- Can be co-administered with routine childhood vaccines
Contraindications
- Hypersensitivity to vaccine components
- Severe Combined Immunodeficiency Disease (SCID)
- History of intussusception
- Ongoing gastroenteritis
Common side effects
- Fever
- Diarrhoea
- Cough
- Irritability
Counselling Points
- Administer orally, do not inject
- Observe hygiene after administration
- Report any adverse reactions
Serious warnings
- Increased risk of intussusception after first dose
- Monitor for symptoms of intussusception
Important Disclaimer
The Rotavac 5D 5 ml Oral liquid professional information leaflet below is the property of The Biovac Institute and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
